Compounds, compositions and methods
US11306077B2 · kind B2 · utility
1Cited by
8References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2021 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | May 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.